Healthcare -
Biotechnology - NASDAQ - US
$ 29.55
1.41 %
$ 4.6 B
Market Cap
-295.5
P/E
TGTX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities TGTX - TG Therapeutics, Inc.
72.7 M
LAST VALUE
32.49%
2 YEAR CAGR
-8.55%
5 YEAR CAGR
6.22%
10 YEAR CAGR